Steven L. Kelly

17.7k citations

246 papers · 10.1k indexed · h-index 58

Infectious Diseases top 0.2%
- Antifungal resistance and susceptibility 66
Pharmacology top 0.05%
- Pharmacogenetics and Drug Metabolism 78
- Fungal Biology and Applications 37
- Microbial Natural Products and Biosynthesis 37
Pharmacology top 0.2%
- Pharmacogenetics and Drug Metabolism 78
- Fungal Biology and Applications 37
- Microbial Natural Products and Biosynthesis 37
Epidemiology top 0.5%
- Fungal Infections and Studies 27
Cell Biology top 1%
Molecular Biology
- Steroid Chemistry and Biochemistry 29
- Fungal and yeast genetics research 25
- Microbial Metabolic Engineering and Bioproduction 24

Co-authors: Diane Kelly David C. Lamb Josie E. Parker Andrew G. S. Warrilow N. J. Manning Michael R. Waterman Venkateswarlu Kanamarlapudi Brian C. Baldwin
Cited by: Infectious Diseases Pharmacology
Journals: Proceedings of the National Academy of Sciences (1 paper)Journal of the American Chemical Society (1 paper)Journal of Biological Chemistry (13 papers)
Partner nations: United Kingdom United States Germany

In The Last Decade

Steven L. Kelly

239 papers receiving 9.9k citations

Peers

Countries citing papers authored by Steven L. Kelly

Since Specialization

Citations

This map shows the geographic impact of Steven L. Kelly's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steven L. Kelly with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steven L. Kelly more than expected).

Fields of papers citing papers by Steven L. Kelly

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Steven L. Kelly. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steven L. Kelly. The network helps show where Steven L. Kelly may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Steven L. Kelly, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Steven L. Kelly Line = papers co-authored together Steven L. Kelly links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Crystal structure of cytochrome P450 NysL and the structural basis for stereo- and regio-selective oxidation of antifungal macrolides Journal of Biological Chemistry ·Vidhi C. Murarka,Jenny S. Kim,David C. Lamb,Steven L. Kelly,T.L. Poulos,Alec H. Follmer	2025	0
2	Exploring medium and long arm extensions of 1,2,4-triazole derivatives as Candida albicans 14α-demethylase (CYP51) inhibitors RSC Medicinal Chemistry ·Marwa Alsulaimany,Faizah A. Binjubair,Esra Tatar,Diane Kelly,Steven L. Kelly,Andrew G. S. Warrilow,Mikhail V. Keniya,Brian C. Monk,Josie E. Parker,Claire Simons	2025	0
3	New Generation Modified Azole Antifungals against Multidrug-Resistant Candida auris Journal of Medicinal Chemistry ·Yiyuan Chen,Yunxiao Li,Kazi S. Nahar,Md. Mahbub Hasan,Caleb Marsh,Melanie Clifford,Godwin A. Aleku,Steven L. Kelly,David C. Lamb,Chengetai D Mpamhanga,Ilias Kounatidis,Ajit J. Shah,Charlotte K. Hind,J. Mark Sutton,Khondaker Miraz Rahman	2025	0
4	Biosynthesis of a new skyllamycin in Streptomyces nodosus: a cytochrome P450 forms an epoxide in the cinnamoyl chain Organic & Biomolecular Chemistry ·Yuhao Song,José A. Amaya,Vidhi C. Murarka,H. Inchaurregui Méndez,Mark T. Hogan,Jimmy Muldoon,Paul Evans,Y. Ortin,Steven L. Kelly,David C. Lamb,T.L. Poulos,Patrick Caffrey	2024	1
5	A secondary mechanism of action for triazole antifungals in Aspergillus fumigatus mediated by hmg1 Nature Communications ·Jeffrey M. Rybak,Jinhong Xie,Adela Martín‐Vicente,Xabier Guruceaga,Harrison I. Thorn,Ashley V. Nywening,Wenbo Ge,Ana Camila Oliveira Souza,Amol C. Shetty,Carrie McCracken,Vincent M. Bruno,Josie E. Parker,Steven L. Kelly,Hannah Marie Snell,Christina A. Cuomo,P. David Rogers,Jarrod R. Fortwendel	2024	22
6	Vertebrate endocrine disruptors induce sex-reversal in blue mussels Scientific Reports ·K. Garrett Evensen,Emily Rusin,William E. Robinson,Claire Price,Steven L. Kelly,David C. Lamb,Jared V. Goldstone,Helen C. Poynton	2024	1
7	Molecular Characterization and Sterol Profiles Identify Nonsynonymous Mutations in ERG2 as a Major Mechanism Conferring Reduced Susceptibility to Amphotericin B in Candida kefyr Microbiology Spectrum ·Mohammad Asadzadeh,Wadha Alfouzan,Josie E. Parker,Jacques F. Meis,Steven L. Kelly,Leena Joseph,Suhail Ahmad	2023	9
8	Species-Specific Differences in C-5 Sterol Desaturase Function Influence the Outcome of Azole Antifungal Exposure Cronfa (Swansea University) ·Josie E. Parker,Steven L. Kelly	2021	6
9	Degradation of a leather-dye by the combination of depolymerised wood-chip biochar adsorption and solid-state fermentation with Trametes villosa SCS-10 Bioresources and Bioprocessing ·Santiago Ortiz-Monsalve,Mariliz Gutterres,Patrícia Valente,Jersson Plácido,S. Bustamante-López,Diane Kelly,Steven L. Kelly	2020	10
10	Azole Antifungal Sensitivity of Sterol 14α-Demethylase (CYP51) and CYP5218 from Malassezia globosa Scientific Reports ·Andrew G. S. Warrilow,Claire Price,Josie E. Parker,Nicola J. Rolley,Christopher J. Smyrniotis,David D. Hughes,Vera Thoss,W. David Nes,Diane Kelly,Theodore R. Holman,Steven L. Kelly	2016	16
11	The Clinical Candidate VT-1161 Is a Highly Potent Inhibitor of Candida albicans CYP51 but Fails To Bind the Human Enzyme Antimicrobial Agents and Chemotherapy ·Andrew G. S. Warrilow,Claire M. Hull,Josie E. Parker,Edward P. Garvey,W. HOEKSTRA,William R. Moore,Robert J. Schotzinger,Diane Kelly,Steven L. Kelly	2014	134
12	Antifungal activity of azole compounds CPA18 and CPA109 against azole-susceptible and -resistant strains of Candida albicans Journal of Antimicrobial Chemotherapy ·Elena Concetta Calabrese,Sabrina Castellano,Marisabella Santoriello,Cristina Sgherri,Mike Frank Quartacci,Lucia Calucci,Andrew G. S. Warrilow,David C. Lamb,Steven L. Kelly,Ciro Milite,Ilaria Granata,Gianluca Sbardella,G. STEFANCICH,Bruno Maresca,Amalia Porta	2013	16
13	Differential inhibition of Candida albicans CYP51 with azole antifungal stereoisomers FEMS Microbiology Letters ·David C. Lamb,Diane Kelly,Brian C. Baldwin,Franco Gozzo,Paul E. Boscott,William G. Richards,Steven L. Kelly	2006	19
14	Cytochrome b5 modulation of 17α hydroxylase and 17–20 lyase (CYP17) activities in steroidogenesis Journal of Endocrinology ·M. Akhtar,Steven L. Kelly,M A Kaderbhai	2005	82
15	The biodiversity of microbial cytochromes P450 Advances in microbial physiology ·Steven L. Kelly,David C. Lamb,Colin J. Jackson,Andrew G. S. Warrilow,Diane Kelly	2003	57
16	The Extraction and Analysis of Sterols from Yeast Humana Press eBooks ·Michael A. Quail,Steven L. Kelly	2003	34
17	Cytochrome P450 3A4 mediated metabolism of 2,4-dichlorophenol Chemosphere ·Zahid Mehmood,Diane Kelly,Steven L. Kelly	1997	23
18	Progesterone biotransformation by human P4503A4 in yeast Biotechnology Letters ·Zahid Mehmood,Diane Kelly,Steven L. Kelly	1995	8
19	Studies on azole-induced cell death inSaccharomyces cerevisiae FEMS Microbiology Letters ·Steven L. Kelly,S. Kenna,Anna Arnoldi,Diane Kelly	1994	4
20	Observations of an extreme form of late eccentric lytic fission inSchizosaccharomyces pombe FEMS Microbiology Letters ·H. F. J. Bligh,Steven L. Kelly	1990	2

About Steven L. Kelly

Steven L. Kelly is a scholar working on Pharmacology, Pharmacology and Infectious Diseases, having authored 246 papers that have together received 10.1k indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (78 papers), Antifungal resistance and susceptibility (66 papers), Fungal Biology and Applications (37 papers), Microbial Natural Products and Biosynthesis (37 papers), Steroid Chemistry and Biochemistry (29 papers), Fungal Infections and Studies (27 papers), Fungal and yeast genetics research (25 papers) and Microbial Metabolic Engineering and Bioproduction (24 papers). The work is most often cited by research in Infectious Diseases (3.8k citations), Pharmacology (1.6k citations) and Pharmacology (2.1k citations). Steven L. Kelly has collaborated with scholars based in United Kingdom, United States and Germany. Frequent co-authors include Diane Kelly, David C. Lamb, Josie E. Parker, Andrew G. S. Warrilow, N. J. Manning, Michael R. Waterman, Venkateswarlu Kanamarlapudi, Brian C. Baldwin, Colin J. Jackson and Claire Price. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Journal of Biological Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact